RELMADA THERAPEUTICS, INC. Human Resources Contracts & Agreements

33 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (11 contracts)
Compensation Agreements (4)
Consulting Agreements (6)
Employment Agreements (9)
Non-Competition Agreements (2)
Separation Agreements (1)

Recent Contracts

Retention Compensation Agreement, effective as of August 27, 2024, between Relmada Therapeutics, Inc. and Paul Kelly (Filed With SEC on January 6, 2025)
Retention Compensation Agreement, effective as of August 27, 2024, between Relmada Therapeutics, Inc. and Charles Ence (Filed With SEC on January 6, 2025)
Retention Compensation Agreement, effective as of August 27, 2024, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on January 6, 2025)
Retention Compensation Agreement, effective as of August 27, 2024, between Relmada Therapeutics, Inc. and Sergio Traversa (Filed With SEC on January 6, 2025)
Amended and Restated Employment Agreement, effective as of January 1, 2025, between Relmada Therapeutics, Inc. and Charles Ence (Filed With SEC on January 6, 2025)
Amended and Restated Employment Agreement, effective as of January 1, 2025, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on January 6, 2025)
Amended and Restated Employment Agreement, effective as of January 1, 2025, between Relmada Therapeutics, Inc. and Sergio Traversa (Filed With SEC on January 6, 2025)
Employment Agreement, effective as of January 1, 2025, between Relmada Therapeutics, Inc. and Paul Kelly (Filed With SEC on January 6, 2025)
Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on May 25, 2023)
Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on June 1, 2022)
Relmada Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on May 20, 2021)
Relmada Therapeutics, Inc., 2021 Equity Incentive Plan (Filed With SEC on March 24, 2021)
Severance and Separation Agreement, dated April 1, 2020, by and between Ottavio Vitolo and Relmada Therapeutics, Inc (Filed With SEC on May 15, 2020)
Employment Agreement, dated March 7, 2020, by and between Thomas Wessel and Relmada Therapeutics, Inc (Filed With SEC on March 12, 2020)
Amendment No. 5 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on March 9, 2020)
Amended and Restated Employment Agreement, dated January 9, 2020, by and between Sergio Traversa and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)
Employment Agreement, dated January 9, 2020, by and between Charles Ence and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)
Employment Agreement, dated January 9, 2020, by and between Maged Shenouda and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)
Consulting Agreement, dated July 29, 2019, by and between Charles S. Ence and Relmada Therapeutics, Inc (Filed With SEC on July 29, 2019)
Amendment No. 4 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 15, 2019)
Consulting Agreement, effective March 25, 2019, between Relmada Therapeutics, Inc. and Najib Babul (Filed With SEC on February 13, 2019)
Third Amendment to the 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 14, 2018)
Consulting Agreement Termination Agreement, dated November 13, 2017, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on November 14, 2017)
Consulting Agreement, dated June 12, 2017, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on September 28, 2017)
Consulting Agreement, dated February 15, 2017, between Relmada Therapeutics, Inc. and MDB Consulting LLC (Filed With SEC on September 28, 2017)
AMENDMENT NO. 2 TO RELMADA THERAPEUTICS, INC. 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on February 10, 2017)
ADVISORY AND CONSULTING AGREEMENT (Filed With SEC on August 7, 2015)
RELMADATHERAPEUTICS, INC. FIRSTAMENDMENT TO THE 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN (Filed With SEC on August 7, 2015)
RelmadaTherapeutics, Inc. 2014STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION1. PURPOSE (Filed With SEC on December 9, 2014)
Relmada Therapeutics, Inc. 2012 STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION 1. PURPOSE (Filed With SEC on May 27, 2014)
COPY NON-DISCLOSURE, ASSIGNMENT OF INVENTIONS, NON-SOLICITATION AND NON-COMPETE AGREEMENT (Filed With SEC on May 27, 2014)
EMPLOYMENT AGREEMENT (Filed With SEC on May 27, 2014)
NON-DISCLOSURE, ASSIGNMENT OF INVENTIONS, NON-SOLICITATION AND NON-COMPETE AGREEMENT (Filed With SEC on May 27, 2014)